Codexis Inc (CDXS)
3.92
+0.58
(+17.37%)
USD |
NASDAQ |
May 03, 16:00
3.92
0.00 (0.00%)
After-Hours: 20:00
Codexis Cash from Operations (Quarterly): -11.04M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.04M |
| September 30, 2023 | -16.30M |
| June 30, 2023 | -16.09M |
| March 31, 2023 | -9.212M |
| December 31, 2022 | 4.917M |
| September 30, 2022 | 19.73M |
| June 30, 2022 | -2.181M |
| March 31, 2022 | -11.19M |
| December 31, 2021 | 0.66M |
| September 30, 2021 | -0.192M |
| June 30, 2021 | -8.295M |
| March 31, 2021 | -6.44M |
| December 31, 2020 | -1.492M |
| September 30, 2020 | -3.474M |
| June 30, 2020 | -10.07M |
| March 31, 2020 | -1.425M |
| December 31, 2019 | -3.661M |
| September 30, 2019 | -0.99M |
| June 30, 2019 | -5.058M |
| March 31, 2019 | -2.851M |
| December 31, 2018 | -0.72M |
| September 30, 2018 | -1.233M |
| June 30, 2018 | -7.956M |
| March 31, 2018 | -4.185M |
| December 31, 2017 | 7.626M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.85M |
| June 30, 2017 | -7.965M |
| March 31, 2017 | -3.566M |
| December 31, 2016 | 5.163M |
| September 30, 2016 | -7.21M |
| June 30, 2016 | -0.032M |
| March 31, 2016 | 0.219M |
| December 31, 2015 | 7.156M |
| September 30, 2015 | 0.431M |
| June 30, 2015 | -4.172M |
| March 31, 2015 | -3.848M |
| December 31, 2014 | 4.974M |
| September 30, 2014 | 1.686M |
| June 30, 2014 | -3.934M |
| March 31, 2014 | -2.405M |
| December 31, 2013 | -3.905M |
| September 30, 2013 | -8.533M |
| June 30, 2013 | -7.073M |
| March 31, 2013 | -3.487M |
| December 31, 2012 | -4.737M |
| September 30, 2012 | -3.863M |
| June 30, 2012 | -3.885M |
| March 31, 2012 | 0.593M |
| December 31, 2011 | -2.896M |
| September 30, 2011 | 2.749M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-16.30M
Minimum
Sep 2023
19.73M
Maximum
Sep 2022
-4.305M
Average
-3.661M
Median
Dec 2019
Cash from Operations (Quarterly) Benchmarks
| Avidity Biosciences Inc | 16.50M |
| Taysha Gene Therapies Inc | -16.12M |
| Janux Therapeutics Inc | -9.901M |
| Tango Therapeutics Inc | -27.47M |
| 2seventy bio Inc | -63.60M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 1.104M |
| Free Cash Flow | -57.06M |
| Free Cash Flow Per Share (Quarterly) | -0.1533 |
| Free Cash Flow to Equity (Quarterly) | -10.66M |
| Free Cash Flow to Firm (Quarterly) | -10.66M |
| Free Cash Flow Yield | -21.37% |